Presentation TCT 2016 TCT 764: Effects of Multielectrode Renal Denervation on Sympathetic Nerve Activity and Insulin Resistance in Metabolic Syndrome Presenter: Melvin D. Lobo, Adam Witkowski, Vasilios Papademetriou October 31, 2016
Presentation TCT 2016 TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a Real World Patient Population With Uncontrolled Hypertension Presenter: Melvin D. Lobo, Adam Witkowski October 31, 2016
Presentation TCT 2016 TCT 763: Alcohol-Mediated Renal Denervation Current Status and Future Directions Presenter: Melvin D. Lobo, Adam Witkowski October 31, 2016
Presentation TCT 2016 TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry Presenter: Melvin D. Lobo, Adam Witkowski October 31, 2016
Presentation TCT 2016 Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Adam Witkowski October 30, 2016
Presentation TCT 2016 Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Vivek Y. Reddy October 30, 2016
Presentation TCT 2016 Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Farrell O. Mendelsohn October 30, 2016
Presentation TCT 2016 Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies Presenter: Ajay J. Kirtane, Bryan Williams, William B. White October 30, 2016
Presentation TCT 2016 Pacing-based Treatments of Hypertension: BackBeat Medical Presenter: Ajay J. Kirtane, Bryan Williams, Karl-Heinz Kuck October 30, 2016
Presentation TCT 2016 Shunt-based Technologies for Hypertension Control: The Rox Medical Program Presenter: Ajay J. Kirtane, Bryan Williams, Paul A. Sobotka October 30, 2016
Presentation TCT 2016 Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies Presenter: Ajay J. Kirtane, Bryan Williams, Wilko Spiering October 30, 2016
Presentation TCT 2016 Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results Presenter: Ajay J. Kirtane, Bryan Williams, Atul Pathak October 30, 2016
Presentation TCT 2016 Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Martin B. Leon October 30, 2016
Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Justin E. Davies October 30, 2016
Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Kona WAVE IV Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Boston Scientific REINFORCE Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Ajay J. Kirtane October 30, 2016